Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
152.50
0.00 (0.00%)
Apr 28, 2026, 1:30 PM CST
25.51%
Market Cap 10.19B
Revenue (ttm) 2.75M
Net Income (ttm) -79.68M
Shares Out 66.80M
EPS (ttm) -1.19
PE Ratio n/a
Forward PE n/a
Dividend 0.10 (0.07%)
Ex-Dividend Date Jun 10, 2025
Volume 145,556
Average Volume 136,440
Open 152.00
Previous Close 152.50
Day's Range 149.00 - 155.00
52-Week Range 122.00 - 317.00
Beta 0.35
RSI 33.61
Earnings Date May 8, 2026

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan. [Read more]

Sector Healthcare
Founded 2016
Employees 27
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.